© 1993 British Society for Rheumatology
review-article |
THE MOLECULAR BASIS OF THE SSA/Ro ANTIGENS AND THE CLINICAL SIGNIFICANCE OF THEIR AUTOANTIBODIES
Rheumatology Unit, Department of Medicine, Hadassah University Hospital Jerusalem, Israel
Correspondence to:
Correspondence to E. Ben-Chetrit, Department of Medicine. Rheumatology Unit, Hadassah University Hospital, POB 12000, Jerusalem, Israel 91120
The SSA/Ro antigens are nuclear and cytoplasmic polypeptides which serve as autoantigens in systemic lupus erythemato-sus (SLE) and Sjögren's syndrome (SS). They contain two major isoforms of 60 and 52 kD. The former is the native antigen while the latter is a major autoantigen in its denatured form. A third protein of 46 kD termed ‘calreticulin-Ro’ is an autoantigen found in the sera of some patients with SLE. However, it is probably unrelated to the SSA/Ro system. The clinical relevance of anti SSA/Ro antibodies in rheumatic diseases has also been considered. Initially these antibodies were thought to be an epiphenomenon of autoimmune diseases. Recent studies have shown that they are associated with specific clinical manifestations and disease subsets. Furthermore, animal models have demonstrated that they may enhance tissue damage. It seems that anti-SSA/Ro antibodies may play a role in the pathogenicity of SLE and SS.
KEY WORDS: SSA/Ro antigen, Autoantibodies, Systemic lupus erythematosus, Sjögren's syndrome
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  I Peene, L Meheus, E M Veys, and F De Keyser Diagnostic associations in a large and consecutively identified population positive for anti-SSA and/or anti-SSB: the range of associated diseases differs according to the detailed serotype Ann Rheum Dis, December 1, 2002; 61(12): 1090 - 1094. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Watanabe, T. Tsuchida, N. Kanda, K. Mori, Y. Hayashi, and K. Tamaki Anti-{alpha}-Fodrin Antibodies in Sjogren Syndrome and Lupus Erythematosus Arch Dermatol, May 1, 1999; 135(5): 535 - 539. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M-K Sire, H Julkunen, R Kaaja, P Kurki, and S Koskimies Role of HLA in congenital heart block: susceptibility alleles in mothers Lupus, January 1, 1999; 8(1): 52 - 59. [Abstract] [PDF]
|
|
|
|
|
|
M Fujimoto, M Shimozuma, N Yazawa, M Kubo, H Ihn, S Sato, T Tamaki, K Kikuchi, and K Tamaki Prevalence and clinical relevance of 52-kDa and 60-kDa Ro/SS-A autoantibodies in Japanese patients with systemic sclerosis Ann Rheum Dis, November 1, 1997; 56(11): 667 - 670. [Abstract] [Full Text]
|
|
|
|
|
|
F. Lopez-Longo, I. Monteagudo, C. Gonzalez, R. Grau, and L. Carreno Systemic lupus erythematosus: clinical expression and anti-Ro/SS--A response in patients with and without lesions of subacute cutaneous lupus erythematosus Lupus, January 1, 1997; 6(1): 32 - 39. [Abstract] [PDF]
|
|
|
|
 |
|
 G. Fabini, R. Raijmakers, S. Hayer, M. A. Fouraux, G. J. M. Pruijn, and G. Steiner The Heterogeneous Nuclear Ribonucleoproteins I and K Interact with a Subset of the Ro Ribonucleoprotein-associated Y RNAs in Vitro and in Vivo J. Biol. Chem., June 1, 2001; 276(23): 20711 - 20718. [Abstract] [Full Text] [PDF]
|
|